Hazard
97 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 97 failed dissolution recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 5 (5%) are Severe.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all failed dissolution recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Novartis is recalling specific lots of Diovan (valsartan) 160 mg tablets because they failed to meet required dissolution specifications.
Supernus Pharmaceuticals is recalling Trokendi XR (topiramate) capsules because they failed dissolution specifications. The recall covers 15,853 bottles distributed nationwide.
Lannett Niacin Extended-release Tablets, 1,000 mg, are being recalled after a stability test returned an out-of-specification low result for Stage 3 dissolution at 24 hours.
Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, are being recalled after failing dissolution specifications, with olmesartan medoxomil content below specification.
Major Pharmaceuticals is recalling one lot of Memantine Hydrochloride Extended-Release Capsules, 7 mg, after the product failed dissolution specifications.
Viatris is recalling one lot of Xanax XR (alprazolam) extended-release tablets, 3 mg, after the product failed dissolution specifications.
Teva Pharmaceuticals is recalling six lots of Metoprolol Succinate Extended-Release Tablets 100 mg after the product failed dissolution specifications.
Teva Pharmaceuticals is recalling six lots of Metoprolol Succinate Extended-Release Tablets 25 mg after the product failed dissolution specifications.
Mylan Pharmaceuticals is recalling two lots of Amnesteem (Isotretinoin) Capsules 40 mg after the product failed dissolution specifications.
Teva Pharmaceuticals is recalling three lots of Metoprolol Succinate Extended-Release Tablets 200 mg after the product failed dissolution specifications.
Teva Pharmaceuticals is recalling six lots of Metoprolol Succinate Extended-Release Tablets 50 mg after the product failed dissolution specifications.
AvKARE is recalling one lot of Amantadine HCl 100 mg capsules after an out-of-specification finding in dissolution testing.
Golden State Medical Supply is recalling 24,869 bottles of Niacin Extended-Release Tablets USP 1,000 mg for failed dissolution specifications.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 50 mg after an out-of-specification dissolution result at the 12-month stability station.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 30 mg after an out-of-specification dissolution result at the 12-month stability station.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 70 mg after an out-of-specification dissolution result at the 12-month stability station.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 10 mg after an out-of-specification dissolution result at the 12-month stability station.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 60 mg after an out-of-specification dissolution result at the 12-month stability station.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 40 mg after an out-of-specification dissolution result at the 12-month stability station.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 20 mg after an out-of-specification dissolution result at the 12-month stability station.
Lannett is recalling 46,848 bottles of Niacin Extended-release Tablets USP 1,000 mg across several lots for failed dissolution specifications.
Ascend Laboratories is recalling 141,984 bottles of Atorvastatin Calcium Tablets USP 10 mg for failed dissolution specifications.
Ascend Laboratories is recalling several lots of Atorvastatin Calcium Tablets USP 20 mg for failed dissolution specifications.
Ascend Laboratories is recalling several lots of Atorvastatin Calcium Tablets USP 40 mg for failed dissolution specifications.
Ascend Laboratories is recalling several lots of Atorvastatin Calcium Tablets USP 80 mg for failed dissolution specifications.